Publication | Closed Access

A multicenter phase II study of sunitinib in patients with locally advanced or metastatic differentiated, anaplastic or medullary thyroid carcinomas: mature data from the THYSU study

Thysu StudyMedicineMedullary Thyroid CarcinomasThyroid DiseaseMature DataPathologyThyroid HormoneOncologyRadiation OncologyMolecular Oncology